{"id":5436,"date":"2014-12-04T09:37:00","date_gmt":"2014-12-04T09:37:00","guid":{"rendered":"https:\/\/aspree.org\/aus\/?p=5436"},"modified":"2021-08-17T07:14:06","modified_gmt":"2021-08-17T07:14:06","slug":"a-letter-from-aspree-pi-prof-john-mcneil-to-australian-participants-and-gp-associate-investigators","status":"publish","type":"post","link":"https:\/\/aspree.org\/aus\/a-letter-from-aspree-pi-prof-john-mcneil-to-australian-participants-and-gp-associate-investigators\/","title":{"rendered":"A letter from ASPREE PI, Professor John McNeil, to Australian participants and GPs"},"content":{"rendered":"\r\n<h2 class=\"wp-block-heading\">To our ASPREE participants and\u00a0GP Associate Investigators,<\/h2>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>The ASPREE team sincerely thanks you for supporting the ASPREE study. Without your ongoing support for medical research, this significant trial would not be possible.<\/p>\r\n\r\n\r\n\r\n<p>For the next three years, ASPREE will be in the \u2018observational\u2019 stage until the trial concludes in 2017.<\/p>\r\n\r\n\r\n\r\n<p>This three year period is critical to determine the findings of the study.<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-5437\" src=\"https:\/\/aspree.org\/wp-content\/uploads\/sites\/2\/2021\/03\/Prof_John_McNeil_Monash-e1429681710587.jpg\" alt=\"\" width=\"723\" height=\"624\" srcset=\"https:\/\/aspree.org\/wp-content\/uploads\/sites\/2\/2021\/03\/Prof_John_McNeil_Monash-e1429681710587.jpg 723w, https:\/\/aspree.org\/wp-content\/uploads\/sites\/2\/2021\/03\/Prof_John_McNeil_Monash-e1429681710587-480x414.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 723px, 100vw\" \/>\r\n<figcaption><em>Above: ASPREE Principal Investigator in Australia, <a href=\"\/aus\/about-us\/\">Prof John McNeil,<\/a> penned an open letter to 16,500 Australian ASPREE trial participants and their GPs as the trial moves from recruitment to the next phase.<\/em><\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n<p>What participation in the \u2018observation\u2019 stage of the trial will involve:<\/p>\r\n\r\n\r\n\r\n<ul>\r\n<li>We ask ASPREE participants to please continue to take your daily study medication and attend annual study visits with our research staff.<\/li>\r\n<li>Even if participants have to come off study medication on the advice of a doctor, we hope to see you at annual study visits. You are still very important to this study!<\/li>\r\n<li>We will endeavour to call our participants approximately every 3 months between annual visits to see how you are.<\/li>\r\n<li>If a participant finds it difficult to attend a study visit, there are a number of options we can discuss to make follow-up easier for you.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>With the help of ASPREE participants and GP Associate Investigators over the next 3 years, we will learn about changes in health with and without aspirin. For this, we thank you.<\/p>\r\n\r\n\r\n\r\n<p>If you have a question about the study please go to our FAQs on the website or feel free to contact the ASPREE team on 1800 728 745 (toll free from a landline). View the open letter from Prof. McNeil <a href=\"\/wp-content\/uploads\/sites\/2\/2021\/03\/JMEnd_of_-recruitmentletter_Dec2014.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a>.<\/p>\r\n\r\n\r\n\r\n<pre class=\"wp-block-preformatted\"><em>Updated 22.03.2021<\/em><\/pre>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Australian ASPREE Principal Investigator, Prof. John McNeil pens an open letter to participants and GPs as the recruitment phase closes.<\/p>\n","protected":false},"author":2,"featured_media":5451,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"882","footnotes":""},"categories":[17,18],"tags":[72],"_links":{"self":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5436"}],"collection":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/comments?post=5436"}],"version-history":[{"count":8,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5436\/revisions"}],"predecessor-version":[{"id":8469,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/5436\/revisions\/8469"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media\/5451"}],"wp:attachment":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media?parent=5436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/categories?post=5436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/tags?post=5436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}